Orbimed Advisors as of June 30, 2016
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 133 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | 5.6 | $541M | 23M | 23.37 | |
| Amgen (AMGN) | 4.8 | $462M | 3.0M | 152.15 | |
| Abbvie (ABBV) | 4.2 | $407M | 6.6M | 61.91 | |
| Bristol Myers Squibb (BMY) | 3.9 | $372M | 5.1M | 73.55 | |
| Biogen Idec (BIIB) | 3.8 | $363M | 1.5M | 241.82 | |
| Alexion Pharmaceuticals | 3.6 | $348M | 3.0M | 116.76 | |
| Allergan | 3.6 | $345M | 1.5M | 231.09 | |
| Hca Holdings (HCA) | 3.3 | $316M | 4.1M | 77.01 | |
| Gilead Sciences (GILD) | 2.7 | $256M | 3.1M | 83.42 | |
| Celgene Corporation | 2.5 | $237M | 2.4M | 98.63 | |
| WellCare Health Plans | 2.1 | $206M | 1.9M | 107.28 | |
| Thermo Fisher Scientific (TMO) | 2.1 | $204M | 1.4M | 147.76 | |
| Intuitive Surgical (ISRG) | 2.1 | $197M | 298k | 661.41 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.0 | $188M | 2.2M | 86.02 | |
| Incyte Corporation (INCY) | 1.9 | $186M | 2.3M | 79.98 | |
| Regeneron Pharmaceuticals (REGN) | 1.9 | $178M | 510k | 349.23 | |
| UnitedHealth (UNH) | 1.8 | $171M | 1.2M | 141.20 | |
| Impax Laboratories | 1.8 | $170M | 5.9M | 28.82 | |
| Intercept Pharmaceuticals In | 1.7 | $160M | 1.1M | 142.68 | |
| Agilent Technologies Inc C ommon (A) | 1.6 | $158M | 3.6M | 44.36 | |
| Pfizer (PFE) | 1.6 | $149M | 4.2M | 35.21 | |
| Teva Pharmaceutical Industries (TEVA) | 1.4 | $139M | 2.8M | 50.23 | |
| Relypsa | 1.4 | $137M | 7.4M | 18.50 | |
| Ironwood Pharmaceuticals (IRWD) | 1.4 | $130M | 9.9M | 13.07 | |
| Express Scripts Holding | 1.3 | $129M | 1.7M | 75.80 | |
| Medivation | 1.3 | $121M | 2.0M | 60.30 | |
| Wright Medical Group Nv | 1.3 | $121M | 6.9M | 17.37 | |
| Illumina (ILMN) | 1.2 | $119M | 846k | 140.38 | |
| BioMarin Pharmaceutical (BMRN) | 1.2 | $118M | 1.5M | 77.80 | |
| Eli Lilly & Co. (LLY) | 1.2 | $116M | 1.5M | 78.75 | |
| Cooper Companies | 1.2 | $116M | 676k | 171.57 | |
| Merck & Co (MRK) | 1.1 | $110M | 1.9M | 57.61 | |
| Molina Healthcare (MOH) | 1.1 | $109M | 2.2M | 49.90 | |
| Ophthotech | 1.1 | $110M | 2.1M | 51.03 | |
| Zimmer Holdings (ZBH) | 1.1 | $104M | 863k | 120.38 | |
| Johnson & Johnson (JNJ) | 1.0 | $94M | 778k | 121.30 | |
| Achillion Pharmaceuticals | 0.9 | $91M | 12M | 7.80 | |
| Puma Biotechnology (PBYI) | 0.9 | $88M | 3.0M | 29.79 | |
| Allergan Plc pfd conv ser a | 0.9 | $87M | 104k | 833.58 | |
| Glaukos (GKOS) | 0.9 | $85M | 2.9M | 29.16 | |
| Neurocrine Biosciences (NBIX) | 0.9 | $83M | 1.8M | 45.45 | |
| Mallinckrodt Pub | 0.8 | $80M | 1.3M | 60.78 | |
| Corvus Pharmaceuticals (CRVS) | 0.8 | $77M | 5.4M | 14.26 | |
| Shire | 0.8 | $73M | 394k | 184.08 | |
| Magellan Health Services | 0.8 | $72M | 1.1M | 65.77 | |
| Humana (HUM) | 0.6 | $61M | 340k | 179.88 | |
| Insys Therapeutics | 0.6 | $61M | 4.7M | 12.94 | |
| Medtronic (MDT) | 0.6 | $58M | 666k | 86.77 | |
| Intellia Therapeutics (NTLA) | 0.6 | $57M | 2.7M | 21.35 | |
| Bluebird Bio (BLUE) | 0.5 | $51M | 1.2M | 43.29 | |
| Edwards Lifesciences (EW) | 0.5 | $51M | 511k | 99.73 | |
| Loxo Oncology | 0.5 | $50M | 2.2M | 23.18 | |
| Insmed (INSM) | 0.5 | $43M | 4.4M | 9.86 | |
| Spdr S&p 500 Etf (SPY) | 0.4 | $42M | 200k | 209.47 | |
| CIGNA Corporation | 0.4 | $42M | 330k | 127.99 | |
| SPDR S&P Biotech (XBI) | 0.4 | $40M | 745k | 54.08 | |
| Eagle Pharmaceuticals (EGRX) | 0.4 | $40M | 1.0M | 38.79 | |
| Array BioPharma | 0.4 | $39M | 11M | 3.56 | |
| Dynavax Technologies (DVAX) | 0.4 | $35M | 2.4M | 14.58 | |
| Intra Cellular Therapies (ITCI) | 0.4 | $34M | 885k | 38.82 | |
| Dimension Therapeutics | 0.3 | $32M | 5.4M | 6.00 | |
| Viewray (VRAYQ) | 0.3 | $33M | 8.0M | 4.09 | |
| Otonomy | 0.3 | $29M | 1.9M | 15.88 | |
| Ascendis Pharma A S (ASND) | 0.3 | $29M | 2.2M | 13.27 | |
| Lion Biotechnologies | 0.3 | $27M | 3.4M | 8.10 | |
| Stryker Corporation (SYK) | 0.3 | $25M | 212k | 119.83 | |
| EXACT Sciences Corporation (EXAS) | 0.3 | $26M | 2.1M | 12.25 | |
| Selecta Biosciences (RNAC) | 0.3 | $26M | 1.8M | 13.99 | |
| Tenet Healthcare Corporation (THC) | 0.3 | $25M | 915k | 27.64 | |
| Synergy Pharmaceuticals | 0.2 | $23M | 6.0M | 3.80 | |
| Immunomedics Inc note 4.750% 2/1 | 0.2 | $21M | 30M | 0.69 | |
| ImmunoGen | 0.2 | $19M | 6.1M | 3.08 | |
| Galapagos Nv- (GLPG) | 0.2 | $20M | 353k | 55.47 | |
| eHealth (EHTH) | 0.2 | $18M | 1.3M | 14.02 | |
| Newlink Genetics Corporation | 0.2 | $18M | 1.6M | 11.26 | |
| Cynapsus Therapeutics | 0.2 | $18M | 1.1M | 15.32 | |
| Sinovac Biotech (SVA) | 0.2 | $16M | 2.7M | 5.93 | |
| Xencor (XNCR) | 0.2 | $17M | 871k | 18.99 | |
| D Fluidigm Corp Del (LAB) | 0.2 | $16M | 1.7M | 9.03 | |
| Natera (NTRA) | 0.2 | $15M | 1.3M | 12.06 | |
| Aetna | 0.1 | $14M | 117k | 122.13 | |
| NuVasive | 0.1 | $15M | 247k | 59.72 | |
| Forward Pharma A/s | 0.1 | $15M | 798k | 18.17 | |
| Cardinal Health (CAH) | 0.1 | $13M | 166k | 78.01 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.1 | $14M | 53k | 257.34 | |
| Jazz Pharmaceuticals (JAZZ) | 0.1 | $13M | 90k | 141.31 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $11M | 2.3M | 4.84 | |
| Pieris Pharmaceuticals (PIRS) | 0.1 | $12M | 7.3M | 1.61 | |
| Inotek Pharmaceuticals | 0.1 | $10M | 1.4M | 7.44 | |
| Abbott Laboratories (ABT) | 0.1 | $9.3M | 237k | 39.31 | |
| Affimed Therapeutics B V | 0.1 | $9.4M | 3.8M | 2.48 | |
| Cellectis S A (CLLS) | 0.1 | $9.3M | 350k | 26.59 | |
| Nabriva Therapeutics | 0.1 | $9.9M | 1.3M | 7.50 | |
| Immunomedics | 0.1 | $8.8M | 3.8M | 2.32 | |
| Portola Pharmaceuticals | 0.1 | $8.8M | 371k | 23.60 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $8.3M | 169k | 48.91 | |
| Sientra | 0.1 | $8.9M | 1.4M | 6.58 | |
| McKesson Corporation (MCK) | 0.1 | $8.1M | 43k | 186.66 | |
| Alkermes (ALKS) | 0.1 | $7.4M | 172k | 43.22 | |
| Assembly Biosciences | 0.1 | $7.8M | 1.4M | 5.55 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $7.5M | 757k | 9.85 | |
| Incyte Corp. note 1.250 11/1 | 0.1 | $7.2M | 4.3M | 1.69 | |
| Incyte Corp note 0.375%11/1 | 0.1 | $7.1M | 4.3M | 1.66 | |
| Aeglea Biotherapeutics | 0.1 | $6.6M | 1.4M | 4.86 | |
| C.R. Bard | 0.1 | $5.4M | 23k | 235.17 | |
| Redhill Biopharma Ltd cmn | 0.1 | $6.1M | 565k | 10.87 | |
| Fluidigm Corporation convertible cor | 0.1 | $6.1M | 10M | 0.61 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $5.9M | 724k | 8.15 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $4.3M | 3.3M | 1.33 | |
| Valeant Pharmaceuticals Int | 0.0 | $3.9M | 195k | 20.14 | |
| Advaxis | 0.0 | $3.6M | 445k | 8.09 | |
| Macrogenics (MGNX) | 0.0 | $4.0M | 149k | 26.99 | |
| Invitae (NVTAQ) | 0.0 | $3.4M | 457k | 7.39 | |
| Minerva Neurosciences | 0.0 | $3.3M | 322k | 10.21 | |
| Seres Therapeutics (MCRB) | 0.0 | $2.5M | 86k | 29.05 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.0 | $2.5M | 12M | 0.21 | |
| Uniqure Nv (QURE) | 0.0 | $1.4M | 195k | 7.37 | |
| Roka Bioscience | 0.0 | $1.8M | 3.2M | 0.57 | |
| Orexigen Therapeutics Inc. 144a 2 3/4% Due 12/1/2020 Jd1 note 2.750%12/0 | 0.0 | $2.2M | 5.2M | 0.42 | |
| Amedisys (AMED) | 0.0 | $1.0M | 20k | 50.50 | |
| Qlt | 0.0 | $710k | 500k | 1.42 | |
| Amarin Corporation (AMRN) | 0.0 | $756k | 350k | 2.16 | |
| Pernix Therapeutics Holdings | 0.0 | $483k | 1.1M | 0.45 | |
| Biolinerx Ltd-spons | 0.0 | $831k | 1.0M | 0.80 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.0 | $555k | 500k | 1.11 | |
| Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.0 | $580k | 500k | 1.16 | |
| Marinus Pharmaceuticals | 0.0 | $1.1M | 868k | 1.27 | |
| Cogentix Medical | 0.0 | $951k | 991k | 0.96 | |
| Xtant Med Holdings | 0.0 | $908k | 475k | 1.91 | |
| Medigus | 0.0 | $1.1M | 600k | 1.82 | |
| Alimera Sciences | 0.0 | $308k | 250k | 1.23 | |
| Aralez Pharmaceuticals | 0.0 | $225k | 68k | 3.30 | |
| Beigene (BGNE) | 0.0 | $385k | 13k | 29.79 |
